Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hong T.A. Le"'
Autor:
Liem Thanh Nguyen, Duc M. Hoang, Kien T. Nguyen, Duc M. Bui, Hieu T. Nguyen, Hong T.A. Le, Van T. Hoang, Hue T. H. Bui, Phuong T.M. Dam, Xuan T.A. Hoang, Anh T.L. Ngo, Hang M. Le, Nhi Y. Phung, Duc M. Vu, Trung T. Duong, Tu D. Nguyen, Lien T. Ha, Hoa T.P. Bui, Hoa K. Nguyen, Michael Heke, Anh V. Bui
Publikováno v:
Stem Cells Translational Medicine, Vol 10, Iss 9, Pp 1266-1278 (2021)
Abstract Human bone marrow‐derived mesenchymal stem/stromal cells (BM‐MSCs) represent promising stem cell therapy for the treatment of type 2 diabetes mellitus (T2DM), but the results of autologous BM‐MSC administration in T2DM patients are con
Externí odkaz:
https://doaj.org/article/885d126be3154d5fb0ff43b21e0f3d18
Autor:
Michael Heke, Hoa T. P. Bui, Hong T.A. Le, Trung T. Duong, Nhi Y. Phung, Hue T. H. Bui, Hieu T. Nguyen, Duc Minh Vu, Hoa K. Nguyen, Xuan T.A. Hoang, Duc M. Hoang, Van T. Hoang, Kien T. Nguyen, Hang M. Le, Lien T. Ha, Phuong T. M. Dam, Anh Viet Bui, Tu D. Nguyen, Anh T. L. Ngo, Liem Thanh Nguyen, Duc M. Bui
Publikováno v:
Stem Cells Translational Medicine
Stem Cells Translational Medicine, Vol 10, Iss 9, Pp 1266-1278 (2021)
Stem Cells Translational Medicine, Vol 10, Iss 9, Pp 1266-1278 (2021)
Human bone marrow‐derived mesenchymal stem/stromal cells (BM‐MSCs) represent promising stem cell therapy for the treatment of type 2 diabetes mellitus (T2DM), but the results of autologous BM‐MSC administration in T2DM patients are contradictor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e2f9fe39f8b61e2c100254cfffa762
https://pubmed.ncbi.nlm.nih.gov/34080789
https://pubmed.ncbi.nlm.nih.gov/34080789